WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017054831) USE OF HUMAN DERIVED IMMUNOSUPPRESSIVE PROTEINS AND PEPTIDES AS MEDICAMENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/054831    International Application No.:    PCT/DK2016/050316
Publication Date: 06.04.2017 International Filing Date: 30.09.2016
Chapter 2 Demand Filed:    31.07.2017    
IPC:
C07K 14/005 (2006.01), A61K 38/16 (2006.01)
Applicants: AIMVION A/S [DK/DK]; Åbogade 15 8200 Aarhus N (DK)
Inventors: LASKA, Magdalena Janina; (DK).
TROLDBORG, Anne Margrethe; (DK).
STENGAARD-PEDERSEN, Kristian; (DK).
BAHRAMI, Shervin; (DK)
Agent: INSPICOS P/S; (DK)
Priority Data:
PA 2015 70620 01.10.2015 DK
PA 2016 70634 23.08.2016 DK
Title (EN) USE OF HUMAN DERIVED IMMUNOSUPPRESSIVE PROTEINS AND PEPTIDES AS MEDICAMENTS
(FR) UTILISATION DE PROTÉINES ET DE PEPTIDES IMMUNOSUPPRESSEURS HUMAINS COMME MÉDICAMENTS
Abstract: front page image
(EN)The present invention concerns uses of immune modulating and immune suppressing peptides from human endogenous retrovirues. In particular, the present invention concerns a use of an immune suppressive peptide for immune suppression and for reduction of inflammation.
(FR)La présente invention concerne des utilisations de peptides modulant la réponse immunitaire et réprimant la réponse immunitaire, issus de rétrovirus endogènes à l'homme. En particulier, la présente invention concerne l'utilisation d'un peptide immunosuppresseur pour réprimer la réponse immunitaire et pour diminuer l'inflammation.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)